Tregoning Kathleen 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Dec 28, 2023
Insider Transaction Report
Form 4
Tregoning Kathleen
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-12-26$10.05/sh+3,150$31,658→ 10,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-26−3,150→ 255,082 totalExercise: $10.05Exp: 2030-07-29→ Common Stock (3,150 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on July 28, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.